Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides
文献情報
F. Nici, G. Oliviero, A. P. Falanga, S. D'Errico, M. Marzano, D. Musumeci, D. Montesarchio, S. Noppen, C. Pannecouque, G. Piccialli, N. Borbone
By combining the ability of short G-rich oligodeoxyribonucleotides (ODNs) containing the sequence 5′CGGA3′ to form higher order G-quadruplex (G4) complexes with the tetra-end-linked (TEL) concept to produce aptamers targeting the HIV envelope glycoprotein 120 (gp120), three new TEL-ODNs (1–3) having the sequence 5′CGGAGG3′ were synthesized with the aim of studying the effect of G4 dimerization on their anti-HIV activity. Furthermore, in order to investigate the effect of the groups at the 5′ position, the 5′ ends of 1–3 were left uncapped (1) or capped with either the lipophilic dimethoxytrityl (DMT) (2) or the hydrophilic glucosyl-4-phosphate (3) moieties. The here reported results demonstrate that only the DMT-substituted TEL-ODN 2 is effective in protecting human MT-4 cell cultures from HIV infection (76% max protection), notwithstanding all the three new aptamers proved to be capable of forming stable higher order dimeric G4s when annealed in K+-containing buffer, thus suggesting that the recognition of a hydrophobic pocket on the target glycoprotein by the aptamers represents a main structural feature for triggering their anti-HIV activity.
関連文献
Bypassing the requirement for aminoacyl-tRNA by a cyclodipeptide synthase enzyme
Christopher J. Harding, Emmajay Sutherland, Jane G. Hanna, Douglas R. Houston, Clarissa M. Czekster
DOI: 10.1039/D0CB00142B
In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptides
Mickal Nawatha, Betsegaw Lemma, Ganga B. Vamisetti, Ido Livneh, Uri Barash, Israel Vlodavsky, Aaron Ciechanover, David Fushman, Hiroaki Suga, Ashraf Brik
DOI: 10.1039/D0CB00179A
Immunopharmacotherapeutic advancements in addressing methamphetamine abuse
Jinny Claire Lee, Kim D. Janda
DOI: 10.1039/D0CB00165A
Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens
Tyrza van Leeuwen, Can Araman, Linda Pieper Pournara, Arieke S. B. Kampstra, Thomas Bakkum, Mikkel H. S. Marqvorsen, Clarissa R. Nascimento, G. J. Mirjam Groenewold, Willemijn van der Wulp, Marcel G. M. Camps, George M. C. Janssen, Peter A. van Veelen, Gerard J. P. van Westen, Antonius P. A. Janssen, Bogdan I. Florea, Herman S. Overkleeft, Ferry A. Ossendorp, René E. M. Toes, Sander I. van Kasteren
DOI: 10.1039/D1CB00009H
Optogenetic modulation of real-time nanoscale dynamics of HCN channels using photoactivated adenylyl cyclases
Meenakshi Tanwar, Suneel Kateriya, Deepak Nair, Mini Jose
DOI: 10.1039/D0CB00124D
Tranylcypromine specificity for monoamine oxidase is limited by promiscuous protein labelling and lysosomal trapping
Jonas Drechsel, Christina Kyrousi, Silvia Cappello, Stephan A. Sieber
DOI: 10.1039/D0CB00048E
Metal transport mechanism of the cation diffusion facilitator (CDF) protein family – a structural perspective on human CDF (ZnT)-related diseases
Shiran Barber-Zucker, Arie Moran, Raz Zarivach
DOI: 10.1039/D0CB00181C
Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications
Adeline Espinasse, Hannah K. Lembke, Angela A. Cao
DOI: 10.1039/D0CB00078G
こちらもおすすめ
2-メトキシ-4-(メチルスルフィニル)アミンの主な用途は何ですか?
2-メトキシ-4-(メチルスルフィニル)アミンは、主に医薬品および農薬の製造に使用されます。また、合成化学の一部として研究用材料としても利用されます。
4,6-二氯-N-甲基ピラミジンアミンの代替品はありますか?
代替品としては、4,6-二クロロピラミジンアミンや他のピラミジン系化合物が考えられます。ただし、目的と用途によって最適な代替品は異なります。
6-氯-4-甲基-1H-吲哚を含む廃棄物はどのように処理すべきですか?
6-氯-4-甲基-1H-吲哚の廃棄物は、適切な容器に収集し、密閉して保管します。温度は常温、湿度は低く、直射日光を避けて保管することを推奨します。廃棄処理は専門...
2-フローユロ-4-(トリフルオロメチル)ベンゾイドについて「に適用される法規ガイドラインは何ですか」
2-フローユロ-4-(トリフルオロメチル)ベンゾイドのCAS番号は207974-08-1です。この化合物はGHS分類で毒性物質と有害な反応物質として分類されます...
4-ニトロフェニルN-[(ベンゼルオキシルカーボンイル]グリシングリシングリシン酸はどのように保存すればよいですか?
4-ニトロフェニルN-[(ベンゼルオキシルカーボンイル]グリシングリシングリシン酸は、室温で暗所に保管し、乾燥した環境で保存することを推奨します。容器は密閉性の...
イソデスロラタドリンの代替品はありますか?
イソデスロラタドリンの代替品としては、デスロラタドリンや他の抗ヒスタミン薬が挙げられます。具体的には、デスロラタドリン、ラセカミド、フェルタドリンなどが、症状や...
5-甲氧基-1,2,3,4-四氢异喹啉盐酸盐はどのように合成されますか?
5-甲氧基-1,2,3,4-四氢异喹啉盐酸盐の一般的な合成方法は、メタノール中で5-メトキシ-1,2,3,4-四ヒュドロイソキシンを塩酸で塩化します。この反応で...
4-アミノ-5-メトキシ-2-トルエンサルホニック酸についての法規ガイドラインは何ですか?
CAS番号6471-78-9の4-アミノ-5-メトキシ-2-トルエンサルホニック酸は、GHS分類では corrosive(腐食性)と識別されます。EUのREAC...
甲基孕酮を取り扱う際の実験室安全事項は何ですか?
甲基孕酮の取り扱いは、PPE(個人保護具)の使用が必要な重要な安全事項を伴います。防塵マスク、ゴーグル、手袋を着用することが推奨されます。ドラフトチャンバーを使...
掲載誌
Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.














